Skip to main content

Find Clinical Trials

Home
Conditions
Hemorrhagic Fever, Ebola

Clinical trial condition

Hemorrhagic Fever, Ebola

Explore clinical trials studying Hemorrhagic Fever, Ebola. Study availability and eligibility vary by location and protocol.

77 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Hemorrhagic Fever, Ebola trial results

Completed

Ebola and Marburg Virus Vaccines

NCT00605514

Conditions: Animal Diseases, Ebola Vaccines, Ebola Virus Disease, +12 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Experimental Vaccine for Prevention of Ebola Virus Infection

NCT00374309

Conditions: Ebola Hemorrhagic Fever, Ebola Virus Disease, Ebola Virus Vaccines, +9 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)

NCT02283099

Conditions: Filoviridae Infections, Hemorrhagic Fever, Ebola, Hemorrhagic Fevers, Viral, +4 more
Locations: CTC North GmbH & Co. KG Hamburg, Germany

View Trial Details

Completed

Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults

NCT02718469

Conditions: Ebola Virus Disease, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: Optimal Research Melbourne, Florida, United States

View Trial Details

Completed

Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults

NCT02564575

Conditions: Filoviridae Infections, Hemorrhagic Fever, Ebola, Hemorrhagic Fevers, Viral, +4 more
Locations: Center for Immunization Research (CIR), Johns Hopkins Bloomberg School of Public Health (JHBSPH) Baltimore, Maryland, United States

View Trial Details

Completed

A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease Vaccine

NCT02575456

Conditions: Ebola Disease, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: Dr. Alie H Wurie Freetown, Sierra Leone

View Trial Details

Completed

A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430

NCT02319772

Conditions: Ebola Virus Infection, Filoviridae Infections, Filovirus Infections, +6 more
Locations: Quotient Clinical Ruddington, United Kingdom

View Trial Details

Completed

A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland

NCT02289027

Conditions: Ebola Vaccines, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: Clinical Trial Unit Lausanne Lausanne, Switzerland

View Trial Details

Completed

Efficacy of Favipiravir Against Severe Ebola Virus Disease

NCT02662855

Conditions: Ebola Virus Disease, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: Not specified

View Trial Details

Completed

Evaluation of the FilmArray BioThreat-E Test

NCT02658331

Conditions: Ebola Virus Disease, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: Not specified

View Trial Details